Digital ACT

DEVICE5 trials

Sponsors

Swing Therapeutics, Inc.

Conditions

Fibromyalgia

Phase 2

SMART-FM: Smart-Phone Based Digital Therapeutic for Management of Fibromyalgia

CompletedNCT05005351

Swing Therapeutics, Inc.Fibromyalgia

Start: 2020-10-28End: 2021-07-09Updated: 2023-08-01

Phase 3

Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

CompletedNCT05243511

Swing Therapeutics, Inc.Fibromyalgia

Start: 2022-02-08End: 2023-05-15Updated: 2023-06-15

Unknown Phase

REACT-FM Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia

CompletedNCT05011162

Swing Therapeutics, Inc.Fibromyalgia

Start: 2021-07-25End: 2024-03-05Updated: 2024-06-27

REACT-FM-EXT: Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study

CompletedNCT05149222

Swing Therapeutics, Inc.Fibromyalgia

Start: 2021-11-30End: 2024-04-14Updated: 2024-07-16

Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management: An Extension Study

CompletedNCT05433337

Swing Therapeutics, Inc.Fibromyalgia

Start: 2022-06-08End: 2024-03-05Updated: 2024-06-27

Related Papers

Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial.

2024-07-0818 citations

Self-guided digital acceptance and commitment therapy for fibromyalgia management: results of a randomized, active-controlled, phase II pilot clinical trial.

2023-06-2915 citations